Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2007-4-20
pubmed:abstractText
An enterotoxigenic Escherichia coli (ETEC) vaccine could reduce diarrhea among children in developing countries and travelers to these countries. The heat-labile toxin (LT) of ETEC is immunogenic but too toxic for oral or nasal vaccines.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0264-410X
pubmed:author
pubmed:issnType
Print
pubmed:day
4
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3684-91
pubmed:dateRevised
2008-8-20
pubmed:meshHeading
pubmed-meshheading:17313998-Administration, Cutaneous, pubmed-meshheading:17313998-Adolescent, pubmed-meshheading:17313998-Adult, pubmed-meshheading:17313998-Antibodies, Bacterial, pubmed-meshheading:17313998-Bacterial Toxins, pubmed-meshheading:17313998-Diarrhea, pubmed-meshheading:17313998-Double-Blind Method, pubmed-meshheading:17313998-Enterotoxins, pubmed-meshheading:17313998-Escherichia coli, pubmed-meshheading:17313998-Escherichia coli Infections, pubmed-meshheading:17313998-Escherichia coli Proteins, pubmed-meshheading:17313998-Escherichia coli Vaccines, pubmed-meshheading:17313998-Feces, pubmed-meshheading:17313998-Humans, pubmed-meshheading:17313998-Immunization, pubmed-meshheading:17313998-Immunoglobulin A, pubmed-meshheading:17313998-Middle Aged, pubmed-meshheading:17313998-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
pubmed:affiliation
Division of Infectious Diseases, Johns Hopkins University, Johns Hopkins Bayview Medical Center, 4940 Eastern Ave., Baltimore, MD 21224, United States. rmckenz@jhmi.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't